302 related articles for article (PubMed ID: 24298311)
21. Application of biomaterials to advance induced pluripotent stem cell research and therapy.
Tong Z; Solanki A; Hamilos A; Levy O; Wen K; Yin X; Karp JM
EMBO J; 2015 Apr; 34(8):987-1008. PubMed ID: 25766254
[TBL] [Abstract][Full Text] [Related]
22. Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine: A Scientific Statement From the American Heart Association.
Musunuru K; Sheikh F; Gupta RM; Houser SR; Maher KO; Milan DJ; Terzic A; Wu JC;
Circ Genom Precis Med; 2018 Jan; 11(1):e000043. PubMed ID: 29874173
[TBL] [Abstract][Full Text] [Related]
23. Future prospects for regenerated heart using induced pluripotent stem cells.
Fujita J; Fukuda K
J Pharmacol Sci; 2014; 125(1):1-5. PubMed ID: 24739283
[TBL] [Abstract][Full Text] [Related]
24. Development of pluripotent stem cells for vascular therapy.
Volz KS; Miljan E; Khoo A; Cooke JP
Vascul Pharmacol; 2012; 56(5-6):288-96. PubMed ID: 22387745
[TBL] [Abstract][Full Text] [Related]
25. Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.
Jung JH; Fu X; Yang PC
Circ Res; 2017 Jan; 120(2):407-417. PubMed ID: 28104773
[TBL] [Abstract][Full Text] [Related]
26. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
Budniatzky I; Gepstein L
Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
[TBL] [Abstract][Full Text] [Related]
27. iPSC technology-based regenerative therapy for diabetes.
Kondo Y; Toyoda T; Inagaki N; Osafune K
J Diabetes Investig; 2018 Mar; 9(2):234-243. PubMed ID: 28609558
[TBL] [Abstract][Full Text] [Related]
28. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
29. Prospects of induced pluripotent stem cell technology in regenerative medicine.
Zhang F; Citra F; Wang DA
Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
[TBL] [Abstract][Full Text] [Related]
30. Is Human-induced Pluripotent Stem Cell the Best Optimal?
Wang F; Kong J; Cui YY; Liu P; Wen JY
Chin Med J (Engl); 2018 Apr; 131(7):852-856. PubMed ID: 29578130
[TBL] [Abstract][Full Text] [Related]
31. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells.
Cong X; Zhang SM; Ellis MW; Luo J
Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827
[TBL] [Abstract][Full Text] [Related]
32. Human iPSC banking: barriers and opportunities.
Huang CY; Liu CL; Ting CY; Chiu YT; Cheng YC; Nicholson MW; Hsieh PCH
J Biomed Sci; 2019 Oct; 26(1):87. PubMed ID: 31660969
[TBL] [Abstract][Full Text] [Related]
33. Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives.
Fus-Kujawa A; Mendrek B; Trybus A; Bajdak-Rusinek K; Stepien KL; Sieron AL
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067183
[TBL] [Abstract][Full Text] [Related]
34. [Breakthrough in research on pluripotent stem cells and their application in medicine].
Valdimarsdóttir G; Richter A
Laeknabladid; 2015 Dec; 101(12):581-6. PubMed ID: 26656400
[TBL] [Abstract][Full Text] [Related]
35. Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.
Panda A; Gurusamy N; Rajasingh S; Carter HK; Thomas EL; Rajasingh J
Differentiation; 2020; 112():58-66. PubMed ID: 31954271
[TBL] [Abstract][Full Text] [Related]
36. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
[TBL] [Abstract][Full Text] [Related]
37. Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies.
Jung YW; Hysolli E; Kim KY; Tanaka Y; Park IH
Curr Opin Neurol; 2012 Apr; 25(2):125-30. PubMed ID: 22357218
[TBL] [Abstract][Full Text] [Related]
38. Clinical applications of patient-specific induced pluripotent stem cells in cardiovascular medicine.
Oh Y; Wei H; Ma D; Sun X; Liew R
Heart; 2012 Mar; 98(6):443-9. PubMed ID: 22285968
[TBL] [Abstract][Full Text] [Related]
39. Human stem cells for modeling heart disease and for drug discovery.
Matsa E; Burridge PW; Wu JC
Sci Transl Med; 2014 Jun; 6(239):239ps6. PubMed ID: 24898747
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of human induced pluripotent stem cells into erythroid cells.
Ebrahimi M; Forouzesh M; Raoufi S; Ramazii M; Ghaedrahmati F; Farzaneh M
Stem Cell Res Ther; 2020 Nov; 11(1):483. PubMed ID: 33198819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
